Currently out of the existing stock ratings of James Shin, 23 are a BUY (45.1%), 28 are a HOLD (54.9%).
Analyst James Shin, currently employed at DEUTSCHE BANK, has had 76.15% of price targets met with an average potential upside of 23.62%, reached in 198 days on average.
James Shin has documented 102 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 26-Mar-2026.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) on 7/23/2024. The price target of $45 was fulfilled within 3 days with a profit of $5.83 (14.88%), with a performance score of 49.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$335
$39.97 (13.55%)
$325
3 days ago
(15-Nov-2026)
Buy Since 17-Nov-2020
$338
$42.97 (14.56%)
$282
17 days ago
(01-Nov-2026)
20/21 (95.24%)
$43.11 (14.62%)
335
Buy Since 07-Dec-2021
$340
$44.97 (15.24%)
$300
17 days ago
(01-Nov-2026)
11/13 (84.62%)
$45.11 (15.30%)
479
Buy Since 05-Apr-2022
$346
$50.97 (17.28%)
$310
17 days ago
(01-Nov-2026)
33/35 (94.29%)
$51.11 (17.33%)
486
Buy Since 15-Nov-2023
$325
$29.97 (10.16%)
$290
17 days ago
(01-Nov-2026)
32/33 (96.97%)
$30.11 (10.21%)
244
What Year was the first public recommendation made by James Shin?